Ilaris

(canakinumab)
1 ML canakinumab 150 MG/ML Injection [Ilaris]
NO BLACK BOX WARNING

Dosage & administration

CAPS:

150 mg for CAPS patients with body weight greater than 40 kg and 2 mg/kg for CAPS patients with body weight greater than or equal to 15 kg and less than or equal to 40 kg. For children 15 to 40 kg with an inadequate response, the dose can be increased to 3 mg/kg. Administer subcutaneously every 8 weeks.

TRAPS, HIDS/MKD, and FMF:


Still’s disease (AOSD and SJIA):

4 mg/kg (with a maximum of 300 mg) for patients with a body weight greater than or equal to 7.5 kg. Administer subcutaneously every 4 weeks.

Most viewed Ilaris resources

Enroll in patient savings program
Coverage Authorization Request - Adult-Onset Still’s Disease & Systemic Juvenile Idiopathic Arthritis
Coverage Authorization Appeal - Adult-Onset Still’s Disease & Systemic Juvenile Idiopathic Arthritis
Letter of Medical Necessity - Adult-Onset Still’s Disease & Systemic Juvenile Idiopathic Arthritis
View more

drug label

Ilaris prescribing information

Have more Ilaris questions?

Submit MSL Request
Learn More

Need to report an Ilaris issue?

ONLINE FORM
Report adverse event
Learn More

prior authorization

Ilaris Prior authorization resources

NOT PROVIDED BY BRAND
Complete Letter of Medical Necessity

NOT PROVIDED BY BRAND
Complete Coverage Authorization request

NOT PROVIDED BY BRAND
Complete Coverage Authorization appeals
Coverage Authorization Request - Adult-Onset Still’s Disease & Systemic Juvenile Idiopathic Arthritis
Coverage Authorization Appeal - Adult-Onset Still’s Disease & Systemic Juvenile Idiopathic Arthritis
Letter of Medical Necessity - Adult-Onset Still’s Disease & Systemic Juvenile Idiopathic Arthritis
Coverage Authorization Request - Cryopyrin-Associated Periodic Syndromes , Tumor Necrosis Factor Receptor Associated Periodic Syndrome , Hyperimmunoglobulin D Syndrome /Mevalonate Kinase Deficiency & Familial Mediterranean Fever
Coverage Authorization Appeal - Cryopyrin-Associated Periodic Syndromes , Tumor Necrosis Factor Receptor Associated Periodic Syndrome , Hyperimmunoglobulin D Syndrome /Mevalonate Kinase Deficiency & Familial Mediterranean Fever
Letter of Medical Necessity - Cryopyrin-Associated Periodic Syndromes , Tumor Necrosis Factor Receptor Associated Periodic Syndrome , Hyperimmunoglobulin D Syndrome /Mevalonate Kinase Deficiency & Familial Mediterranean Fever
Learn More

Benefits investigation

Get Benfits Investigation Support
Service Request Form - Illaris Companion (English )
Service Request Form - Illaris Companion ( Spanish)
Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRAND
Reimbursement help (FRM) resources
Learn More

financial assistance

Ilaris Financial assistance options

Co-pay savings program

commercial only
Enroll in patient savings program
Service Request Form - Illaris Companion (English )
Service Request Form - Illaris Companion ( Spanish)
Learn More

Bridge program

commercial only
Enroll in Bridge Program
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Novartis Patient Assistance Program Application - English
Novartis Patient Assistance Program Application - Spanish
Service Request Form - Illaris Companion (English )
Service Request Form - Illaris Companion ( Spanish)
Learn More

patient education

Ilaris Patient education

Getting started on Ilaris

NOT PROVIDED BY BRAND
Instructions For Use - Adult Onset Still's Disease

NOT PROVIDED BY BRAND
Instructions For Use - Systemic Juvenile Idiopathic Arthritis

NOT PROVIDED BY BRAND
Instructions For Use - Cryopyrin-Associated Periodic Syndromes

NOT PROVIDED BY BRAND
Instructions For Use - Hyperimmunoglobulin D Syndrome/Mevalonate Kinase Deficiency

NOT PROVIDED BY BRAND
Instructions For Use - Familial Mediterranean Fever

NOT PROVIDED BY BRAND
Instructions For Use - Tumor Necrosis Factor Receptor Associated Periodic Syndrome

Patient toolkit

About Ilaris - Adult Onset Still's Disease
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources - Adult Onset Still's Disease
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Ilaris - Systemic Juvenile Idiopathic Arthritis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources - Systemic Juvenile Idiopathic Arthritis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Ilaris - Cryopyrin-Associated Periodic Syndromes
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources - Cryopyrin-Associated Periodic Syndromes
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Ilaris - Hyperimmunoglobulin D Syndrome/Mevalonate Kinase Deficiency
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources - Hyperimmunoglobulin D Syndrome/Mevalonate Kinase Deficiency
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Ilaris - Familial Mediterranean Fever
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources - Familial Mediterranean Fever
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Ilaris - Tumor Necrosis Factor Receptor Associated Periodic Syndrome
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources - Tumor Necrosis Factor Receptor Associated Periodic Syndrome
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Can't find what you're looking for?

Our trained staff can help you:
Please note:
  • Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
  • Samples are provided at the discretion of the brand.
  • We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.